Two HIV Vaccine Trials Show Proof of Concept for Pathway to Broadly Neutralizing Antibodies
May 16, 2025
May 16, 2025
LA JOLLA, California, May 16 (TNSrpt) -- The Scripps Research Institute issued the following news:
* * *
Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies
North American and African clinical trials led by Scripps Research, IAVI and additional collaborators across the U.S. and Africa mark progress toward an effective HIV vaccine.
*
LA JOLLA, CA and NEW YORK, NY--A decades-long scientific cha . . .
* * *
Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies
North American and African clinical trials led by Scripps Research, IAVI and additional collaborators across the U.S. and Africa mark progress toward an effective HIV vaccine.
*
LA JOLLA, CA and NEW YORK, NY--A decades-long scientific cha . . .